Anne-Françoise Nesmes
Prospective Non-Executive Director
Subject to shareholder approval, Anne-Françoise will be appointed as a Board director following the conclusion of the 2025 Annual General Meeting.
Until recently, Anne-Françoise was the Chief Financial Officer at Smith & Nephew Plc, the multinational medical technology company equipment manufacturer, where she led several acquisitions and developed and led a transformation programme following COVID-19. Prior to Smith & Nephew Plc, Anne-Françoise was Chief Financial Officer at Dechra Pharmaceuticals from 2013 to 2016 and Chief Financial Officer at Merlin Entertainments from 2016 to 2020. In these roles, she was responsible for formulating the strategy and streamlining financial processes. Earlier in her career, Anne-Françoise spent 16 years at GlaxoSmithKline in a variety of roles of increasing seniority.
Anne-Françoise holds a Masters in Management Sciences, Finance; MBA and CIMA, accounting qualification.
Prospective Board Committees
Audit and Risk Committee
ESG Committee
External appointments
- Compass Group Plc, senior independent director, chair of the audit committee and member of the remuneration, nomination and corporate responsibility committees.
- Sanofi, non-executive director.